These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19747645)

  • 21. Avoiding Guillan-Barré Syndrome following swine origin pandemic H1N1 2009 influenza vaccination.
    Eisen DP; McBryde ES
    J Infect Dis; 2009 Nov; 200(10):1627-8. PubMed ID: 19857155
    [No Abstract]   [Full Text] [Related]  

  • 22. Influenza vaccine and Guillain-Barré syndrome: making informed decisions.
    Poland GA; Poland CM; Howe CL
    Lancet; 2013 Apr; 381(9876):1437-9. PubMed ID: 23622271
    [No Abstract]   [Full Text] [Related]  

  • 23. The vaccination campaign against 2009 pandemic influenza A(H1N1) and its continued importance in view of the uncertainty surrounding the risk associated with the pandemic.
    Tsiodras S; Sypsa V; Hatzakis A
    Euro Surveill; 2010 Jan; 15(3):. PubMed ID: 20122377
    [No Abstract]   [Full Text] [Related]  

  • 24. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.
    Huang WT; Chen WW; Yang HW; Chen WC; Chao YN; Huang YW; Chuang JH; Kuo HS
    Vaccine; 2010 Oct; 28(44):7161-6. PubMed ID: 20804804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse effects following pandemic influenza (H1N1) 2009 vaccination.
    Bolam B; Grills N
    Aust N Z J Public Health; 2009 Dec; 33(6):584. PubMed ID: 20078579
    [No Abstract]   [Full Text] [Related]  

  • 26. Should I have an H1N1 flu vaccination after Guillain-Barre syndrome?
    Price LC
    BMJ; 2009 Sep; 339():b3577. PubMed ID: 19740925
    [No Abstract]   [Full Text] [Related]  

  • 27. [Planning preventive vaccination of pandemic H1N1 influenza].
    Chevillotte J
    Rev Infirm; 2009 Oct; (154):10. PubMed ID: 19894292
    [No Abstract]   [Full Text] [Related]  

  • 28. Additional seasonal influenza virus vaccinations for the 2009 H1N1 pandemic.
    Qin CF; Jiang T; Han JF; Li XF; Qin ED; Leng QB
    Clin Vaccine Immunol; 2010 May; 17(5):887-8. PubMed ID: 20219879
    [No Abstract]   [Full Text] [Related]  

  • 29. Pandemic influenza vaccine policy--considering the early evidence.
    Neuzil KM
    N Engl J Med; 2009 Dec; 361(25):e59. PubMed ID: 19745213
    [No Abstract]   [Full Text] [Related]  

  • 30. "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events.
    Evans D; Cauchemez S; Hayden FG
    J Infect Dis; 2009 Aug; 200(3):321-8. PubMed ID: 19563262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Well-functioning strategy for the A/H1N1 pandemic in Varmland. A preliminary summary].
    Wik O
    Lakartidningen; 2010 Jun 16-29; 107(24-25):1630-3. PubMed ID: 20687426
    [No Abstract]   [Full Text] [Related]  

  • 32. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Australia's winter with the 2009 pandemic influenza A (H1N1) virus.
    Bishop JF; Murnane MP; Owen R
    N Engl J Med; 2009 Dec; 361(27):2591-4. PubMed ID: 19940287
    [No Abstract]   [Full Text] [Related]  

  • 35. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
    Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
    Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of influenza vaccination: Risk-benefit evaluation.
    Wiwanitkit V
    Muscle Nerve; 2010 Aug; 42(2):296; author reply 296. PubMed ID: 20544931
    [No Abstract]   [Full Text] [Related]  

  • 37. Pandemic influenza: the new wave.
    Lancet Infect Dis; 2009 Oct; 9(10):583. PubMed ID: 19778756
    [No Abstract]   [Full Text] [Related]  

  • 38. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.
    Yih WK; Lee GM; Lieu TA; Ball R; Kulldorff M; Rett M; Wahl PM; McMahill-Walraven CN; Platt R; Salmon DA
    Am J Epidemiol; 2012 Jun; 175(11):1120-8. PubMed ID: 22582207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass psychogenic illness in nationwide in-school vaccination for pandemic influenza A(H1N1) 2009, Taiwan, November 2009-January 2010.
    Huang WT; Hsu CC; Lee PI; Chuang JH
    Euro Surveill; 2010 May; 15(21):19575. PubMed ID: 20519106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Managing pandemic (H1N1) 2009.
    Boland M; O'Herlihy B; O'Brien A; MacDonald P; Crowley D; Kelleher K
    Ir Med J; 2009 Sep; 102(8):267-8. PubMed ID: 19873871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.